Detecting fetal sub-chromosomal aneuploidies
AssigneeVerinata Health, Inc.
InventorsDarya I. Chudova, Diana Abdueva
Life of this patent
Estimating the term…
Loading patent…
AssigneeVerinata Health, Inc.
InventorsDarya I. Chudova, Diana Abdueva
Estimating the term…
Disclosed are methods for determining copy number variation (CNV) known or suspected to be associated with a variety of medical conditions, including syndromes related to CNV of subchromosomal regions. In some embodiments, methods are provided for determining CNV of fetuses using maternal samples comprising maternal and fetal cell free DNA. Some embodiments disclosed herein provide methods to improve the sensitivity and/or specificity of sequence data analysis by removing within-sample GC-content bias. In some embodiments, removal of within-sample GC-content bias is based on sequence data corrected for systematic variation common across unaffected training samples. In some embodiments, syndrome related biases in sample data are also removed to increase signal to noise ratio. Also disclosed are systems for evaluation of CNV of sequences of interest.
A method, implemented at a computer system that includes one or more processors and system memory, for evaluation of copy number of a sequence of interest in a test sample comprising nucleic acids, the method comprising:
A computer program product comprising a non-transitory machine readable medium storing program code that, when executed by one or more processors of a computer system, causes the computer system to implement a method for evaluation of copy number of a sequence of interest, said program code comprising code for:
A system for evaluation of copy number of a sequence of interest related to a genetic syndrome using a test sample comprising nucleic acids, the system comprising:
Dependencies are inferred from the claim text.